RJA
CANF

Raymond James & Associates’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Raymond James & Associates’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5
Closed -$12K – 3654
2019
Q1 		$12K Hold
5
– – ﹤0.01% 3560
2018
Q4 		$17K Hold
5
– – ﹤0.01% 3445
2018
Q3 		$18K Hold
5
– – ﹤0.01% 3545
2018
Q2 		$16K Hold
5
– – ﹤0.01% 3507
2018
Q1 		$20K Buy
5
+1
+25% +$5.52K ﹤0.01% 3381
2017
Q4 		$18K Hold
4
– – ﹤0.01% 3350
2017
Q3 		$21K Hold
4
– – ﹤0.01% 3309
2017
Q2 		$22K Buy
+4
New +$22K ﹤0.01% 3252

Other funds holding CANF

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $1.93B AUM 18.43% 1-Year Est. Return